))
CGM Accuracy with John Pemberton RD, specialist diabetes dietician Department of Endocrinology and Diabetes, Birmingham Children’s Hospital
Manage episode 448431579 series 3605397
Content provided by Dexcom. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dexcom or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
What is MARD as a measure for CGM accuracy? What does it mean and how is it calculated? John Pemberton discusses how to look at accuracy studies across different CGM devices and the differences between CE mark approvals in the UK and USA/Australia. An enlightening listen around something you may see everyday as a healthcare professional but would like to know more about. Link to the study discussed is in the show notes.
With / speaker;
John Pemberton RD specialist diabetes dietician Department of Endocrinology and Diabetes, Birmingham Children’s Hospital
Refs for description
*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
John S Pemberton et al, CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes Obes Metab. 2023; 25(4):916-939.
This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.
Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.
All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom ONE+, Dexcom Share, Share are trademark or registered trademarks in the U.S. and may be in other countries. © 2024 Dexcom, Inc. All rights reserved. Dexcom International, Ltd. and its affiliated European entities. 1 Tanfield, Suite 6, Level 1 Tanfield, Edinburgh EH3 5DA.
Further CPD accredited education can be found on the Dexcom Education Hub
11 episodes
Share
